208
Participants
Start Date
February 20, 2017
Primary Completion Date
July 19, 2018
Study Completion Date
July 19, 2018
FX006 32 mg
Single intra-articular injection
Rochester Clinical Research, Rochester
Altoona Center for Clinical Research, Duncansville
Duke University, Durham
Medical University of South Carolina, Charleston
Coastal Carolina Research Center, Mt. Pleasant
The Andrews Institute, Gulf Breeze
Tampa Bay Medical Research, Clearwater
PMG Research of Knoxville, Knoxville
Ochsner Sports Medicine Institute, New Orleans
Tucson Orthopedic, Tucson
Cedars-Sinai Medical Center, Los Angeles
Harbor-UCLA Medical Center, Torrance
Hope Clinical Research, Canoga Park
Artemis Institute for Clinical Research, San Diego
Dream Team Clinical Research, Anaheim
Brigham and Women's Hospital, Chestnut Hill
New England Baptist Hospital, Dedham
Lead Sponsor
Pacira Pharmaceuticals, Inc
INDUSTRY